It would thus be interesting to investigate if VRK3 depletion is also synthetic lethal in other pediatric tumor entities without hypermethylation of VRK2 promoter, and in particular posterior fossa type A ependymoma and infant high-grade glioma (Figure S3M). This evidence concerns the gene VRK2 and glioma.